Press Releases

Archive: January 2022


Engagement In Big Data Research Dementia Collaboration

IXICO continues its engagement in Dementias Platform UK as it enters its second phase IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it has extended its commitment to Dementias Platform UK (DPUK) as it enters its second phase.

Read more

Non-Executive Director Appointment

IXICO plc, the data analytics company delivering insights in neuroscience, is pleased to announce the appointment of Kate Rogers as a Non-Executive Director and Chair of the Audit Committee with effect from 21 January 2022.

Read more

Huntington's Disease Contract Update

IXICO plc, the data analytics company delivering insights in neuroscience, announces a further update to the Huntington's disease Phase III contract. As previously announced on 23 March 2021, the client decided to stop dosing participants in its Phase III trial in Huntington's disease following a pre-planned review of the data.

Read more